Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are two major types of chronic cholestatic liver disease. Each disorder has distinguishing features and variable progression, but both may ultimately result in cirrhosis and hepatic failure. The following offers a review of PBC and PSC, beginning with a general overview of disease etiology, pathogenesis, diagnosis, clinical features, natural course, and treatment. In addition to commonly associated manifestations of fatigue, pruritus, and fat-soluble vitamin deficiency, select disease-related topics pertaining to women's health are discussed including metabolic bone disease, hyperlipidemia and cardiovascular risk, and pregnancy-related issues influencing maternal disease course and birth outcomes. This comprehensive review of PBC and PSC highlights some unique clinical considerations in the care of female patients with cholestatic liver disease.
Keywords: Cholestasis; Fat-soluble vitamin deficiency; Fatigue; Hyperlipidemia; Metabolic bone disease; Pregnancy; Primary biliary cirrhosis; Primary sclerosing cholangitis; Pruritus; Women's health.
Conflict of interest statement
Complications, symptoms, quality of life and pregnancy in cholestatic liver disease.Liver Int. 2018 Mar;38(3):399-411. doi: 10.1111/liv.13591. Epub 2017 Oct 3. Liver Int. 2018. PMID: 28921801 Review.
Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis.Liver Int. 2015 Jun;35(6):1764-71. doi: 10.1111/liv.12730. Epub 2014 Dec 4. Liver Int. 2015. PMID: 25388280
Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.Curr Treat Options Gastroenterol. 2003 Apr;6(2):93-103. doi: 10.1007/s11938-003-0010-0. Curr Treat Options Gastroenterol. 2003. PMID: 12628068
A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis.J Clin Transl Hepatol. 2014 Mar;2(1):45-52. doi: 10.14218/JCTH.2013.00021. Epub 2014 Mar 15. J Clin Transl Hepatol. 2014. PMID: 26357617 Free PMC article. Review.
Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist.Liver Res. 2019 Jun;3(2):118-127. doi: 10.1016/j.livres.2019.04.001. Epub 2019 May 27. Liver Res. 2019. PMID: 32042471 Free PMC article.
Cited by 4 articles
Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients.Jpn J Radiol. 2019 May;37(5):412-419. doi: 10.1007/s11604-019-00822-6. Epub 2019 Feb 23. Jpn J Radiol. 2019. PMID: 30798469
Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma.J Liver. 2018;7(3):231. doi: 10.4172/2167-0889.1000231. Epub 2018 Sep 20. J Liver. 2018. PMID: 30613437 Free PMC article.
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.Int J Mol Sci. 2018 Oct 1;19(10):3003. doi: 10.3390/ijms19103003. Int J Mol Sci. 2018. PMID: 30275402 Free PMC article. Review.
H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.Hepatology. 2017 Oct;66(4):1183-1196. doi: 10.1002/hep.29209. Epub 2017 Aug 26. Hepatology. 2017. PMID: 28407375 Free PMC article.